ISSN: 2329-6631
Journal of Developing Drugs
Open Access
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)Recommended Conferences
- International Conference on Pain Management and Pain Medicine
May 21-22, 2018 | New York, USA - International Conference on Drug Discovery, Designing and Development
June 27-28, 2018 Vancouver, Canada - International Conference And Exhibition on Drug Safety & Pharmacovigilance
August 29-30, 2018 Toronto, Canada
Recommended Journals
Relevant Topics
- Adverse Drug Reactions
- Antigen â Antibody Reaction
- Anvisa Drug Safety Regulations
- Biochemical Metabolism
- Clinical Pharmacoepidemiological Trails
- Cytochrome 450 Drug Metabolism
- Cytotoxicity
- Detoxification
- Drug Delivery
- Drug Delivery Systems
- Drug Delivery using Nanotechnology
- Drug Designing
- Drug Development
- Drug Discovery
- Drug Interaction
- Drug Interactions
- Drug Metabolism
- Drug Safety Databases
- Drug Safety Information Maintenance
- Drug Safety Regulations
- Drug Therapy
- Drug Toxicology
- Drug drug interaction
- Drug food interaction
- Drugs metabolised by CYP2D6
- Europeon Drug Safety Regulations
- Expert Opinions on Drug Safety
- Fragment Based Drug Design
- Heat Shock Proteins
- Hepatic Metabolism of Drugs
- In Silico Methods
- Liver Drug Metabolism
- Medication Errors
- Molecular Modeling
- Nanomedicals
- Peptidomimetic
- Pharmaceutical Industry
- Pharmaceutical Toxicology
- Pharmacoepidemiological Studies
- Pharmacotherapy
- Phase I Drug Metabolism
- Phase II Drug Metabolism
- Pre-Clinical Drug Development
- Protease Substrate/Inhibitor
- Receptor Agonist/ Antagonist
- Reviews on Drug Safety
- Structure Based Drug Design
- UK Drug Safety Regulations
- US Drug Safety Regulations
- screening and Drug Design
Dev Prasad |
||
|
Massachusetts College of Pharmacy and Health Sciences, Boston, MA USA |
||
| Publications | ||
|
Ternary Amorphous Solid Dispersions Dev Prasad, Jagdish Lande, Hari Chauhan and Harsh Chauhan Editorial: J Dev Drugs 2017 6: 181 |
||
|
|
||
